Tag Archives: hcm

Workday May Hit $5 Billion In 5 Years As Financial Software Rises

At the rate Workday ( WDAY ) is growing its core human capital management (HCM) software, combined with its new financial management products, analysts Ross MacMillan and Matthew Hedberg can see Workday’s path to $5 billion in yearly sales by 2021. The company just hit it first billion-dollar year, closing its fiscal year ended Jan. 31 with sales of $1.16 billion. The pair of RBC Capital Markets analysts on Sunday raised their price target on Workday stock to 92 from 72 and affirmed their outperform rating. Workday stock rose a fraction Monday to a 2016 high, making its seventh consecutive up-day, closing at 78.92. Last week, Workday stock broke out of a cup-with-handle at a 75.60 buy point. Workday wasn’t alone Monday. Rival ServiceNow ( NOW ) rose 3.6%  to 64.28 on a bullish report from William Blair on its long-term fundamentals. Bigger enterprise software rivals Salesforce ( CRM ), Oracle ( ORCL ) and SAP ( SAP ) all slipped a fraction. RBC’s MacMillan and Hedberg drew confidence by comparing Workday to PeopleSoft in 2001, four years before its HCM and financial management (FM) software businesses were acquired by Oracle for $10.4 billion. PeopleSoft co-founder David Duffield, who fought the Oracle takeover, went on to co-found Workday. “A look back at PeopleSoft is striking,” they said. “Workday today has (less than) 25% of PeopleSoft’s customer count in 2001, yet Workday has (more than) 50% of PeopleSoft’s revenue at that time. This is particularly interesting, given Workday has yet to generate any meaningful financial management revenue today and which (according to management) was (more than) 50% of PeopleSoft’s revenue at the time of acquisition by Oracle.” In other words, the RBC analysts say, Workday has plenty of room to grow. “Success in financials would support a path to $5 billion,” they wrote. “While financials (are) not the focus in this note, we think the path to $5 billion revenue remains underpinned (split less than 50% HCM, more than 50% FM) which we think can be realized in the next 5-plus years.” For its fiscal 2016 ended Jan. 31, Workday revenue rose 48% to $1.16 billion. It lost 1 cent per share minus items, a huge improvement from a 33-cent loss in fiscal 2015. Analysts polled by Thomson Reuters expect a Q1 per-share loss minus items of 2 cents, on revenue up 35% to $339 million. They expect adjusted profit to break into the black in Q3.

Software Bounce? Rebound? Workday Leads, But Price Targets Fall

Are long-lagging software stocks ready to rebound? With the major stock market indexes rallying about 2%, even Tableau Software ( DATA ) was up 4% by early afternoon Tuesday. But the real mover is enterprise software developer Workday ( WDAY ), back to work after an anxious Leap Year workday when it unveiled Q4 earnings and revenue that beat Wall Street — for the 13th time in 14 quarters — but then sucked some oxygen out of the room by guiding the current Q1 sales below analyst estimates. The stock edged down in after-hours trade Monday. No matter. Workday stock gapped up 9.1% after the morning bell, then slipped slightly, then rebounded to sit 9.8% higher at 66.40 in midafternoon trading in the stock market today , heading for a fifth straight up day, its ninth in the last 11. Workday stock is still 29% off a three-month high made last May. The entire IBD Computer Software-Enterprise industry group was up 2.3% by midafternoon, also on a five-day win run, boosted by Salesforce.com ‘s ( CRM ) big 11% jump after issuing solid earnings and outlook after the close Feb 24. Salesforce was up 2.3% in afternoon trade Tuesday, while legacy software king Oracle ( ORCL ) was up 2.9% to 37.85. Salesforce is the highest-ranked of the bunch, with an IBD Composite Rating of 88 out of a possible 99, tracking metrics such as earnings growth, stock market performance and other measures. But the Computer Software-Enterprise industry group as a whole ranks just 90th in performance out of 197 tracked by IBD. The Computer Software-Database group, where low-rated Tableau resides, ranks near the bottom, at 184, though both groups have been on an upswing since the second week of February, clambering back from steep losses the prior week. Oracle, Tableau and Workday still hold relatively low IBD Composite Ratings in the 40s. A little momentum at Workday? Analysts differ. They’re impressed, but also cautious. Citing Workday’s “strong billings” — up 44% — with financial management software customers “roughly doubling” year over year to 207 clients, FBN Securities analyst Shebly Seyrafi lowered his price target to 75 from 80 and retained his sector perform rating on Workday, not so much on any weakness at Workday but “due to recent market multiple contraction.” And while revenue guidance for Q1 came in below analyst expectations , “billings guidance was above,” Seyrafi wrote in a research note issued Tuesday. “We are also impressed by WDAY’s strong degree of visibility,” he said. Unearned revenue of $900 million grew by 42%, but noncancelable backlog — not on the balance sheet — grew by 62% to $1.56 billion, he noted. “This results in the combination of unearned revenue and backlog at $2.5 billion, up 54%. Since this represents 82% of our estimated next-eight-quarter subscription revenue, up from 72% at the end of fiscal 2015, WDAY’s visibility has increased.” Similarly, analyst David Hynes lowered Canaccord Genuity’s price target to 75 from 95 but reiterated a buy rating for Workday. “Lots of things happening at Workday,” he wrote in a research note, citing “record new customer adds, Fortune 500 go-lives, triple-digit pipeline growth, improving competitive win rates, increasing attach rates, new SKUs set to hit the market in (the current) fiscal 2017, and the list goes on.” Those new SKUs — stock keeping units, or individual products — in planning, learning management and student software are expected to add “more than” a $5 billion total addressable market for Workday to work over, co-founder and CEO Aneel Bhusri told analysts in a post-earnings conference call late Monday. That’s on top of Workday’s core financial management and human capital management (HCM) software product markets. Then again, Brean Capital analyst Yun Kim warned that billings growth decelerated to 42% in fiscal 2016 from 69% in 2015. “Its fiscal 2017 billings guidance calls for modest 31% growth,” Kim wrote in a research note issued Tuesday. “While overall FY17 revenue and billings guidance was mostly positive, we believe its outlook for flat margins could disappoint some investors,” Kim said. Brean Capital rates Workday a hold with a 60.45 price target. “Overall, given lack of transparency into its new business bookings, we believe there will likely be a high degree of uncertainty that exists among investors regarding its true sales momentum,” Kim wrote. Evercore ISI analyst Kirk Materne lowered his price target to 75 from 95 but maintained a buy rating. “Overall, we believe the longer-term trends in the business remain positive, and WDAY remains one of the best multiyear growth stories in software,” he said in a Tuesday research note. “But given that the market remains wary of high valuation SaaS  (Software as a Service) names, investors will need to take a long-term view.” For the current Q1 2017, Workday guided revenue below analysts’ views to a range of $337 million to $339 million but didn’t forecast earnings. Analysts polled by Thomson Reuters expect on average a Q1 per-share loss minus items of 2 cents, flat with a year ago, on $343.3 million in revenue vs. Q1 2016’s $251 million.

Momentum Traps – How To Avoid The Siren Song Of Overhyped Stocks

Faced with choosing between a $10 bottle of wine and a $90 bottle of wine, which would you go for? In one experiment – with the prices of each wine clearly marked – nearly twice as many people preferred the taste of the most expensive bottle. But unknown to the volunteers, the two wines were exactly the same. This test was carried out by American researchers investigating how pricing can influence the brain’s perception of how ‘pleasant’ something is. Told it’s expensive, we tend to like it all the more. It’s an example of what behavioral scientists say is a flaw in human emotions that causes us to be overly-influenced by a good story. The read across for investors could hardly be more stark. Stories in the stock market are like a magnet. With herds of followers, these popular shares typically boast eye-catching price momentum. Yet a good proportion of them hide deteriorating fundamentals and stretched valuations that can be harder to spot (and, for some, easy to ignore). These are the market’s glamour stocks which may well be Momentum Traps – stocks where a sudden change in sentiment could see their momentum crash. Of all the dangers that investors face, perhaps none is more seductive than the siren song of stories. Stories essentially govern the way we think. We will abandon evidence in favour of a good story – James Montier Signs of a Momentum Trap Small cap stocks soared through 2013, and by early the following year some valuations looked frothy. Swept up in a wave of bullish exuberance, popular ‘blue sky’ companies like Blur ( OTC:BLURF ), Monitise ( OTC:MNQQY ) and Cloudbuy ( OTC:CDLBF ) were showing some of the classic signs of being momentum traps. As sentiment towards small caps drifted through the next 12 months, the price of each share was pummelled. The common traits shared by these and other momentum traps was that their strong price momentum hadn’t been matched by improving fundamentals. Yet, they looked expensive and their low QualityRanks pointed to firms that either weren’t profitable at all or were flagging as potentially distressed. Importantly, these were some of the most talked about small caps at the time, promoted by brokers and heavily traded by investors. They were the polar opposite of traditional ‘value’ shares but investors lapped them up all the same. In The Little Book of Behavioural Investing , James Montier of investment firm GMO, says that one of the reasons why people shy away from value investing is that value shares tend to come with poor stories. As a result, they end up being despised rather than admired. He explains: “Which would you rather own? Psychologically, we know you will feel attracted to the admired stocks. Yet the despised stocks are generally a far better investment. They significantly outperform the market as well as the admired stocks.” Indeed, evidence that momentum stocks underperform dates back to a 1993 study by three researchers who made a personal fortune from their findings. Josef Lakonishok, Andrei Shleifer and Robert Vishny showed that investors consistently overestimate future growth rates of glamour stocks relative to value stocks. They said this was because investors typically make judgement errors and extrapolate too much of the past to make predictions about the future. They proved their point by going on to run billions of dollars in their own fund management firm called LSV. Testing the performance of Momentum Traps In Stockopedia’s taxonomy of stock market winners (and losers), Momentum Traps typically have StockRanks that reflect strong momentum but poor value and quality. We can build a screen for these stocks by setting the following filters: Momentum Rank > 80 (i.e. high Momentum) QV Rank < 40 (i.e. poor combined Quality and Value) Market Cap > 100 (i.e. to focus on the more well-known shares) Top 25 stocks by Momentum Rank (i.e. 25 highest Momentum shares in the set) We’ve used the Stockopedia StockRank archives to generate the performance history of a 25 stock portfolio rebalanced annually since April 2013. The results are quite startling (click to enlarge) What happens so often with Momentum Traps is that they outperform the market dramatically… but only for a while. This strong price performance lulls investors into a false sense of security and draws in the suckers right at the wrong time. Most investors buy these stocks at the top, and suffer terrible underperformance when gravity reasserts itself. As we can see, the Momentum Trap portfolio has tracked the FTSE All Share over the last two-and-a-half years but broken everyone’s hearts in the interim. Through 2013, the Momentum Traps portfolio was very much an all-cap affair, with stocks ranging from 3i ( OTCPK:TGOPY ) to Nanoco ( OTC:NNOCF ) and Blinkx ( OTC:BLNKY ). There were (and continue to be) some stocks that held on to the momentum and did well. But in 2014, it was weighted much more heavily towards small caps. It’s here that the trouble starts. As sentiment cooled towards smaller stocks, those that were overstretched paid the heaviest price. Companies like eServGlobal, Quadrise Fuels ( OTC:QDRSF ), Johnston Press ( OTC:JHPSY ) and a handful of resources shares have continued to slide. Dodging a momentum trap bullet Using the above rules on today’s data set, we’ve compiled a list below of stocks that could see their momentum turn if investor sentiment changes. The companies include some popular names like Hutchison China MediTech (Pending: HCM ) and Optimal Payments ( OTCPK:NVAFF ). Note that the ‘buy’, ‘hold’ and ‘sell’ recommendations of the brokers that cover each company are broadly positive in their outlook. Detailed research may uncover nothing to worry about with these shares. However, QV Ranks of below 40 (out of 100) certainly warrants close attention and suggests things could be more precarious than the broker recommendations infer. Name Momentum Rank QV Rank # Buy Recs # Hold Recs # Sell Recs Admiral ( OTCPK:AMIGY ) 98 25 1 10 2 OneSavings Bank ( OTC:OSVBF ) 98 29 – 4 – Hutchison China MediTech 96 14 – – 1 Optimal Payments 95 29 4 – – Grainger ( OTC:GRGTF ) 94 10 3 4 – Severn Trent ( OTCQX:STRNY ) 94 25 2 9 1 NMC Health ( OTC:NMHLY ) 93 20 6 – – Dignity ( OTC:DGNTY ) 92 37 – 4 – To avoid the lure of stories and the risk of succumbing to momentum traps, investors should be alert when strong momentum is paired with deteriorating fundamentals or excessive valuation. Momentum is one of the strongest drivers of returns in the stock market, and certainly capable of carrying story stocks some distance. But momentum can crash, particularly in shares with heady valuations and suspect quality. It’s a message best summed up by Montier, who says the key is to focus on facts. “Focusing on the cold hard facts (soundly based in real numbers) is likely to be the best defence against the siren song of stories.” Editor’s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.